SMAD4 and colorectal carcinoma: As model systems to investigate the impact of SMAD4mut conditions on EMT processes, we employed two epithelial CRC cell lines which carry homozygous mutations in the SMAD4 gene described to completely abrogate SMAD4 protein expression [26].